259 filings
8-K
IMMU
Immunomedics Inc
23 Oct 20
Completion of Acquisition or Disposition of Assets
5:08pm
8-K
IMMU
Immunomedics Inc
21 Sep 20
Other Events
6:00am
8-K
IMMU
Immunomedics Inc
17 Sep 20
Departure of Directors or Certain Officers
4:38pm
8-K
IMMU
Immunomedics Inc
14 Sep 20
Gilead Sciences to Acquire Immunomedics
8:00am
8-K
IMMU
Immunomedics Inc
17 Aug 20
Approval enhances long-term supply of Trodelvy
8:01am
8-K
zv4dqsnlapk
5 Aug 20
Immunomedics Reports Second Quarter 2020 Results and Provides Corporate Update
5:00pm
8-K
1hl8dx3esyujmb21nab
6 Jul 20
The safety profile of Trodelvy was consistent with the FDA-approved label and no new safety signals were observed
8:07am
8-K
snvds8z50d66p5hr3
18 Jun 20
Departure of Directors or Certain Officers
4:16pm
8-K
febst r70ymqt
27 May 20
Immunomedics Announces Leadership Change and Provides Business Update Amid COVID-19
4:08pm
8-K
3a5n1izt66es 1ullw0x
7 May 20
Departure of Directors or Certain Officers
7:51am
8-K
viv069a5yid8lp1ryx
6 May 20
Immunomedics Reports First Quarter 2020 Results and Provides Corporate Update
4:01pm
8-K
fp1k 3f5lqn
1 May 20
Immunomedics Announces Proposed Public Offering of Common Stock
5:13pm
8-K
ffcj 6eu1
22 Apr 20
FDA Grants Accelerated Approval for Immunomedics’ Trodelvy in Previously-Treated Metastatic Triple-Negative Breast Cancer
12:40pm
8-K
2vhugwy6ih ibj
6 Apr 20
Immunomedics Announces Ascent Study to Be Stopped for Compelling Efficacy
8:05am
8-K
uznal qe92brbnkju
6 Apr 20
Immunomedics Announces Executive Leadership Changes and the Appointment of Harout Semerjian As President and Chief Executive Officer
7:55am
8-K
sqaxfosuou
25 Mar 20
Immunomedics Provides COVID-19 Business Continuity Update, Affirms 2020 Strategic Priorities, and Shares R&D and Regulatory Update
8:02am
8-K
mesxp3jvl6by
27 Feb 20
Immunomedics Appoints Robert W. Azelby to Board of Directors
4:20pm
8-K
vh5ppm5ns2
27 Feb 20
Immunomedics Reports Fourth Quarter and Full Year 2019 Results and Provides Corporate Update
4:01pm
8-K
nfegv0yf8wd4e6n
14 Feb 20
Immunomedics Appoints DR. Loretta Itri Chief Medical Officer
8:10am
8-K
a0xjbu71brw0
26 Dec 19
Other Events
8:01am